Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiogenesis Inhibition in Oncology”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00262327
What this trial is testing

Safety and Efficacy of Adenoviral Endostatin in the Treatment of Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Sun Yat-sen University 20
Not applicableUnknownNCT01656824
What this trial is testing

Tissue Study of Bv8/PK-2 Inhibition in Human Cancer

Who this might be right for
Cancer
Rambam Health Care Campus 20
Testing effectiveness (Phase 2)Study completedNCT00083382
What this trial is testing

Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide

Who this might be right for
Multiple Myeloma
University of Arkansas 83
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Not applicableUnknownNCT04731909
What this trial is testing

Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

Who this might be right for
SCLC, Extensive StageLung CancerSmall Cell Lung Cancer
Third Military Medical University 80
Testing effectiveness (Phase 2)UnknownNCT02930954
What this trial is testing

Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance

Who this might be right for
Non-small-cell Lung Cancer
Caicun Zhou 180
Early research (Phase 1)Study completedNCT01105533
What this trial is testing

A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors

Who this might be right for
Neoplasm
Pfizer 46
Testing effectiveness (Phase 2)Study completedNCT00094107
What this trial is testing

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Who this might be right for
MelanomaSkin Neoplasms
Pfizer 32
Early research (Phase 1)Study completedNCT01445119
What this trial is testing

A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas

Who this might be right for
Recurrent Gliomas
Eli Lilly and Company 58
Testing effectiveness (Phase 2)Ended earlyNCT01778530
What this trial is testing

TRC105 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 2
Not applicableStudy completedNCT07053202
What this trial is testing

TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Hebei Medical University 140
Testing effectiveness (Phase 2)Study completedNCT03417895
What this trial is testing

SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy

Who this might be right for
Small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07083375
What this trial is testing

A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer.

Who this might be right for
Extensive Small Cell Lung Cancer
Zhijie Wang 56
Early research (Phase 1)Study completedNCT00678977
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Gemcitabine and Gemcitabine Plus Cisplatin for Advanced Solid Tumors

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 22
Not applicableEnded earlyNCT01336231
What this trial is testing

Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Who this might be right for
Metastatic Kidney Cancer
Centre Francois Baclesse 82
Testing effectiveness (Phase 2)UnknownNCT01529164
What this trial is testing

Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Chinese Academy of Medical Sciences 51
Testing effectiveness (Phase 2)UnknownNCT03461185
What this trial is testing

Anti-angiogenesis Combine With EGFR-TKI in Advanced Non-squamous Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Xinqiao Hospital of Chongqing 100
Testing effectiveness (Phase 2)Study completedNCT00667394
What this trial is testing

Tandutinib Plus Bevacizumab to Treat Recurrent Brain Tumors

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00076011
What this trial is testing

Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Kidney Neoplasms
Pfizer 52
Next Page